“This NIH funding for our Clemson-MUSC collaboration in bioengineering and regenerative medicine is very exciting. Our vision is to not only continue to support the development of talented young scientists and our biotechnology industry within the state, but to provide an environment that will fundamentally change patient care of the future.” — David J. Cole, MUSC president

“An $11-million grant is a game-changer. That level of funding allows us to attract and retain the kind of talent the state needs to grow its portfolio of med-tech businesses. Jobs in the field start at $60,000 to $80,000.” — John Ballato, Clemson vice president for economic development

“SC BioCRAFT researchers are improving health, one of the 21st century’s grand challenges. The high-impact medical technology they are developing could lead to therapies and cures that help patients around the world. And having the research in Greenville means that it could help create high-paying jobs here in South Carolina. Securing second-phase funding from NIH reflects on the leadership and the high quality of research the team delivers.” — Anand Gramopadhye, dean of Clemson’s College of Engineering and Science

“In its first five years, the center has helped support and mentor 13 junior faculty members who have collectively received more than $10 million in external funding and published 151 journal articles. The center also helped the university recruit three junior and two senior faculty members. We did very well in phase one. We will build on our success in phase two.” — Martine LaBerge, chair of Clemson’s bioengineering department

“SC BioCRAFT is on the cutting-edge of research. With the work our researchers have done and the phase two funding in hand, Clemson and our partners are well-positioned to strengthen the bioengineering and regenerative medicine community in the state and nationally.” — Tanju Karanfil, associate dean for research and graduate studies in Clemson’s College of Engineering and Science

“We can help faculty stay focused on critical, real-world healthcare needs and improving patient care. As physicians, we treat patients daily, allowing us a front-row view of what’s needed in the field.” — Clinical mentor Eugene Langan, M.D., of Greenville Health System

“This is an incredible example of the collaborative impact of research. The COBRE award recognizes Clemson’s long-term research collaboration with both GHS and MUSC. GHS clinical mentors have a proven track record in working closely with Clemson faculty to develop research programs which are clinically relevant and have the potential to transform care. Through the GHS Clinical University, the unique partnership between Clemson bioengineering faculty and GHS surgeons provides an opportunity for research to be truly informed by patient needs.” — Windsor Sherrill, interim associate vice president for health research at Clemson University and interim chief science officer at Greenville Health System